Wednesday, June 17, 2:00 – 3:30 pm
Auditorium Lulli

Chairs: Mark Fox (Switzerland) – Kerry Dunbar (USA)

1. How should the optimal reflux monitoring modality and protocol be selected for different reflux presentations? – Marcelo Vela (USA)
2. Can patients with AET <4% off PPI have actionable GERD? – Wei-Yi (Ray) Lei (Taiwan)
3. How should reflux-symptom association data on reflux monitoring tests be used for planning symptom management? – Riblosi
4. What is the optimal management for reflux hypersensitivity. – Neha Patel (USA)
5. The AET is 4-6% off PPI – now what? – Nicola De Bortoli (Italy)
6. Can total reflux episode count on impedance monitoring direct management? – Benjamin Rogers (USA)
   
   Panel Chat/Q&A
    
7. What methods are available for clinical measurement of esophageal mucosal integrity? – TBD
8. What are the roles of mucosal impedance metrics in evaluating typical and atypical reflux symptoms? – Adriana Lazarescu (Canada)
9. Are there roles for barium esophagram and high-resolution manometry in GERD evaluation? – Stefano Siboni (Italy)
10. How can FLIP be utilized for GERD diagnosis and management? – Abraham Khan (USA)
11. What is the diagnostic approach to suspected reflux-related airway diseases? – TBD
12. How can reflux management protect the lungs in pre- and post-transplant patients? – Wai-Kit Lo (USA)

Panel Chat/Q&A